Takuya Miyagi

5.9k citations
104 papers · 4.0k indexed · h-index 34
Topics
Immune Cell Function and Interaction (32 papers)Hepatitis B Virus Studies (21 papers)Hepatitis C virus research (18 papers)

In The Last Decade

Takuya Miyagi

98 papers receiving 4.0k citations

Peers

Takuya Miyagi
Comparison fields: 5 of 112
  • Immunology 1.8k
  • Molecular Biology 1.3k
  • Epidemiology 1.0k
  • Hepatology 825
  • Oncology 774
Replace Takahiro Kodama with:
Takahiro Kodama Japan
Patrick Bertolino Australia
Hitoshi Asakura Japan
Tomohide Tatsumi Japan
Oliver Waidmann Germany
Hiroyuki Yoneyama Japan
Hiroyuki Marusawa Japan
Simon C. Afford United Kingdom
Laurence B. Peterson United States
Marcus Schuchmann Germany
Takuya Miyagi relative to Takahiro Kodama Japan Takahiro Kodama's profile →
Citations per field
00.5×1.5×
Takahiro Kodama · 1×
Citations per year

Countries citing papers authored by Takuya Miyagi

Since Specialization
Citations

This map shows the geographic impact of Takuya Miyagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Miyagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Miyagi more than expected).

Fields of papers citing papers by Takuya Miyagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Miyagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Miyagi. The network helps show where Takuya Miyagi may publish in the future.

Co-authorship network of co-authors of Takuya Miyagi

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Miyagi. A scholar is included among the top collaborators of Takuya Miyagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Miyagi. Takuya Miyagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 8
3 6
4 2
5 1
6 5
7 20
8 28
9 3
10 1
11 52
12 10
13 73
14 25
15 5
16 102
17 11
18 167
19 143
20 205

About Takuya Miyagi

Takuya Miyagi is a scholar working on Hepatology, Immunology and Dermatology, having authored 104 papers that have together received 4.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (32 papers), Hepatitis B Virus Studies (21 papers) and Hepatitis C virus research (18 papers). The work is most often cited by research in Hepatology (825 citations), Immunology (1.8k citations) and Epidemiology (1.0k citations). Takuya Miyagi has collaborated with scholars based in Japan, United States and South Africa. Frequent co-authors include Tetsuo Takehara, Norio Hayashi, Tomohide Tatsumi, Tatsuya Kanto, Masahisa Jinushi, Atsushi Hosui, Satoshi Shimizu, Hisashi Ishida, Hayato Hikita and Takahiro Suzuki. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026